₹221.30
₹-0.89 (-0.40%)
Closed · As of 26 Aug 3:30 pm
Mkt Cap
₹970 Cr
P/E
14.37
ROE
7.72%
ROCE
9.06%
About Bhageria Industries Ltd
Bhageria Industries engaged in manufacturing and trading of Dyes & Dyes Intermediate, Chemicals, Pharmaceutical, generation and distribution of solar power and Engineering, Procurement & Commissioning construction (EPC) contractor. The equity shares of the Company are listed on the National Stock Exchange of India Limited and BSE Limited.
Founded
1989
CEO
Suresh Bhageria
Employees
406
HQ
Mumbai, Maharashtra
About Bhageria Industries Ltd
Bhageria Industries engaged in manufacturing and trading of Dyes & Dyes Intermediate, Chemicals, Pharmaceutical, generation and distribution of solar power and Engineering, Procurement & Commissioning construction (EPC) contractor. The equity shares of the Company are listed on the National Stock Exchange of India Limited and BSE Limited.
Founded:1989
CEO:Suresh Bhageria
Employees:406
HQ:Mumbai, Maharashtra
Finished Products
1Sales
₹1,893.99Cr2Solar Power
₹28.65Cr3Sale of Solar Electricity
₹26.60Cr4Duty drawback and other expor
₹7.10Cr5Job Work
₹1.86Cr6Duty drawback and Export Incen
₹1.56Cr7Others
₹1.34Cr1–7 of 9
Raw Materials
1Raw Material Consumed
₹1,090.19Cr2Purchases of Trading Stock
₹223.21CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹245
52W Low
₹128
Volume53.24K
Avg VolumeN/A
Beta0.86
Dividend Yield1.12%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
14.37x
Valuation
P/B Ratio
1.63x
Valuation
EPS
₹15.47
Valuation
Dividend Yield
1.12%
Valuation
ROE
7.72%
Profitability
ROCE
9.06%
Profitability
Revenue by Segment
Contribution & growth by business line
Chemical
+64.6%94.9%
₹829.55 Cr
Solar Power
-2.5%3.1%
₹27.13 Cr
Others
-81.1%1.2%
₹10.82 Cr
Pharma
+15.8%0.7%
₹6.45 Cr
Geographical Revenue Split
Domestic vs international exposure
Domestic
65.2%
International
34.8%
Domestic65.2%
Export34.8%
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.17x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
20.9%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.